CDC25B and acute myeloid leukemia: The result shows that the reduced binding of NF-YB on the Cdc25b promoter was observed in IER5 over-expressed AML-derived ALDHhi/CD34+ cells compared to untreated and control DNA transfected cells (Fig. 7, middle panel).